HSD63 Characteristics and Treatment Patterns of Patients Initiating Cladribine Tablets: A U.S. Commercial and Medicare Advantage Prescription Drug Claims Analysis
Dec 1, 2022, 00:00
10.1016/j.jval.2022.09.1406
https://www.valueinhealthjournal.com/article/S1098-3015(22)03611-7/fulltext
Title :
HSD63 Characteristics and Treatment Patterns of Patients Initiating Cladribine Tablets: A U.S. Commercial and Medicare Advantage Prescription Drug Claims Analysis
Citation :
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(22)03611-7&doi=10.1016/j.jval.2022.09.1406
First page :
Section Title :
Open access? :
No
Section Order :
10952